Univec, Inc. (UNVC)

0,0047 -0,0000 (-0,13%) Alla chiusura: 03:49PM EDT

Univec, Inc.

822 Guilford Avenue
Suite 208
Baltimore, MD 21202
United States
410-347-9959
https://www.univec.com

Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. David Dalton	CEO, President & Director	39,93k	N/D	1949
Mr. Michael A. Lesisko	Chief Financial Officer, Secretary and Treasurer	12,5k	N/D	1949
Mr. Raphael Langford	Chief Operating Officer and Executive Vice President	13,33k	N/D	1944

Gli importi risalgono al giorno 31 dicembre 2003 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.

Governance aziendale

L'ISS Governance QualityScore di Univec, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.